Drug Discovery and Development Industry: AndroScience Corporation – Product Pipeline Review – Q1 2011

• Publication date: August 2012
• Report size: 25 pages

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by Global In...

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by Global Industry s Direct’s team.

Scope of the Research

- AndroScience Corporation - Brief industry player overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of AndroScience Corporation human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of AndroScience Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the AndroScience Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate AndroScience Corporation’s strategic position with total access to detailed data on its product pipeline.
- Assess the growth opportunities of AndroScience Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the AndroScience Corporation’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with AndroScience Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of AndroScience Corporation and identify potential opportunities in those areas.

Global Therapy Industry

Table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
AndroScience Corporation Snapshot 4
AndroScience Corporation Overview 4
Key Information 4
Key Facts 4
AndroScience Corporation – Research and Development Overview 5
Key Therapeutic Areas 5
AndroScience Corporation – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
AndroScience Corporation – Pipeline Products Glance 9
AndroScience Corporation Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
AndroScience Corporation–Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
AndroScience Corporation – Drug Profiles 11
ASC-J9 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
ASC-J9 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
ASC-JM 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ASC-JQ 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
AndroScience Corporation – Pipeline Analysis 15
AndroScience Corporation – Pipeline Products by Therapeutic Class 15
AndroScience Corporation – Pipeline Products by Route of Administration 16
AndroScience Corporation – Pipeline Products by Molecule Type 17
AndroScience Corporation – Operations and Subsidiaries 18
Head Office 18
Recent Developments 19
May 26, 2010: AndroScience Corporation Forms Strategic Alliance With Taiwan Based Orient Europharma To Develop November el Topical Acne Therapeutic 19
March 06, 2009: AndroScience Corporation Announces Phase 2a Study Results On ASC-J9 For the Treatment Of Acne 19
September 01, 2007: 2007 – Phase II Clinical Trial In Acne Vulgaris Begins Enrollment 20
January 26, 2007: AndroScience Corporation Enters Clinical Stage 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 22
Contact Us 22
Disclaimer 22

List of Tables

AndroScience Corporation – Pipeline by Therapy Area and Indication, 2011 6
AndroScience Corporation – Pipeline by Stage of Development, 2011 7
AndroScience Corporation – Monotherapy Products in Pipeline, 2011 8
AndroScience Corporation - Phase II, 2011 9
AndroScience Corporation - Pipeline By Therapeutic Class, 2011 15
AndroScience Corporation – Pipeline By Route of Administration, 2011 16
AndroScience Corporation – Pipeline By Molecule Type, 2011 17

List of Figures

AndroScience Corporation – Pipeline by Therapy Area and Indication, 2011 6
AndroScience Corporation – Pipeline by Stage of Development, 2011 7
AndroScience Corporation – Monotherapy Products in Pipeline, 2011 8
AndroScience Corporation – Pipeline By Therapeutic Class, 2011 15
AndroScience Corporation – Pipeline By Route of Administration, 2011 16
AndroScience Corporation – Pipeline By Molecule Type, 2011 17